Corea, artrite, eritema marginato: malattia reumatica e diagnosi differenziali

2020 ◽  
Vol 39 (10) ◽  
pp. 643-650
Author(s):  
Antonino Maria Quintilio Alberio ◽  
Filippo Pieroni ◽  
Giulia Bini ◽  
Alice Bonucelli ◽  
Alessandro Orsini ◽  
...  

Acute rheumatic fever, Rheumatic carditis, Sydenham’s chorea, Erythema marginatum, Arthritis, Differential diagnosis The revision of the Jones criteria by the American Heart Association allowed the identification and diagnosis of a greater number of cases of Rheumatic Disease (RD); however, the higher incidence of RD is associated with "pathomorphic" phenotypic pictures, making the diagnosis more difficult. Chorea, carditis, arthritis, marginatum erythema are the major criteria for the diagnosis of RD and can represent its clinical onset, but likewise, due to the variety of their associations, they open a range of different differential diagnoses. Through the critical reasoning applied to some clinical cases, these major “criteria” of RD have been discussed to reduce the difficulties of the differential diagnosis.


Circulation ◽  
2015 ◽  
Vol 131 (20) ◽  
pp. 1806-1818 ◽  
Author(s):  
Michael H. Gewitz ◽  
Robert S. Baltimore ◽  
Lloyd Y. Tani ◽  
Craig A. Sable ◽  
Stanford T. Shulman ◽  
...  

Background— Acute rheumatic fever remains a serious healthcare concern for the majority of the world’s population despite its decline in incidence in Europe and North America. The goal of this statement was to review the historic Jones criteria used to diagnose acute rheumatic fever in the context of the current epidemiology of the disease and to update those criteria to also take into account recent evidence supporting the use of Doppler echocardiography in the diagnosis of carditis as a major manifestation of acute rheumatic fever. Methods and Results— To achieve this goal, the American Heart Association’s Council on Cardiovascular Disease in the Young and its Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee organized a writing group to comprehensively review and evaluate the impact of population-specific differences in acute rheumatic fever presentation and changes in presentation that can result from the now worldwide availability of nonsteroidal anti-inflammatory drugs. In addition, a methodological assessment of the numerous published studies that support the use of Doppler echocardiography as a means to diagnose cardiac involvement in acute rheumatic fever, even when overt clinical findings are not apparent, was undertaken to determine the evidence basis for defining subclinical carditis and including it as a major criterion of the Jones criteria. This effort has resulted in the first substantial revision to the Jones criteria by the American Heart Association since 1992 and the first application of the Classification of Recommendations and Levels of Evidence categories developed by the American College of Cardiology/American Heart Association to the Jones criteria. Conclusions— This revision of the Jones criteria now brings them into closer alignment with other international guidelines for the diagnosis of acute rheumatic fever by defining high-risk populations, recognizing variability in clinical presentation in these high-risk populations, and including Doppler echocardiography as a tool to diagnose cardiac involvement.



Circulation ◽  
2021 ◽  
Vol 143 (22) ◽  
pp. 2127-2128
Author(s):  
Andrea Beaton ◽  
Kathryn A. Taubert


PEDIATRICS ◽  
1954 ◽  
Vol 13 (3) ◽  
pp. 282-282

The staff of La Rabida Sanitarium, Chicago, announces two 3 day graduate conferences on rheumatic fever and heart disease, to be held March 31 and April 2, 1954, and Oct. 7, 8 and 9, 1954, for pediatricians and practicing physicians. The spring session will precede the Annual Meeting of the American Heart Association in Chicago on April 3 and 4 and also the Areal Meeting of the American Academy of Pediatrics in Los Angeles the following week.



PEDIATRICS ◽  
1982 ◽  
Vol 70 (3) ◽  
pp. 507-507
Author(s):  
Charles M. Ginsburg ◽  
George H. McCracken

Boxerbaum has implied that we have questioned the concept of penicillin prophylaxis for patients with rheumatic fever. We did not! Rather, we provided pharmacologic data demonstrating that the concentrations of penicillin in serum may be inadequate to prevent colonization or disease with group A streptococci or pneumococci 18 days or longer after administration of the doses of benzathine penicillin G that are recommended by the American Heart Association. In fact, Boxerbaum's data support our contention—group A streptococci were isolated from 8% of his patients who had received intramuscular benzathine penicillin.



PEDIATRICS ◽  
1949 ◽  
Vol 4 (6) ◽  
pp. 856-857

This booklet, prepared under the chairmanship of Edward R. Schlesinger, M.D., Director of the Bureau, with the assistance of a group of specialized workers, has been reviewed in detail by the Advisory Committee on Rheumatic Fever in the New York State Department of Health, Composition of this Committee includes for the most part important members of the American Heart Association and the booklet has been approved as a guide by the American Council on Rheumatic Fever.



Sign in / Sign up

Export Citation Format

Share Document